These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28299946)

  • 21. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-EPIFAT trial protocol: a multi-center, randomized, placebo-controlled trial of the efficacy of pharmacotherapy for fatigue using methylphenidate, bupropion, ginseng, and amantadine in advanced cancer patients on active treatment.
    Miladinia M; Jahangiri M; White SJ; Karimpourian H; Inno A; Chan SW; Ganji R; Maniati M; Zarea K; Ghalamkari M; Farahat A; Fagerström C
    Trials; 2024 Apr; 25(1):230. PubMed ID: 38570861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Use of Methylphenidate for Physical and Psychological Symptoms in Cancer Patients: A Review.
    Andrew BN; Guan NC; Jaafar NRN
    Curr Drug Targets; 2018; 19(8):877-887. PubMed ID: 28322161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.
    Sarhill N; Walsh D; Nelson KA; Homsi J; LeGrand S; Davis MP
    Am J Hosp Palliat Care; 2001; 18(3):187-92. PubMed ID: 11406895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot study to determine the optimal dose of methylphenidate for an n-of-1 trial for fatigue in patients with cancer.
    Hardy JR; Carmont SA; O'Shea A; Vora R; Schluter P; Nikles CJ; Mitchell GK
    J Palliat Med; 2010 Oct; 13(10):1193-7. PubMed ID: 20831434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining objective and subjective outcomes in cancer-related fatigue: illustrations from a single case report.
    Khoshknabi DS; Davis MP; Ranganathan VK; Siemionow V; Walsh D; Kirkova J; Yue GH
    J Palliat Med; 2008 Jul; 11(6):829-33. PubMed ID: 18715172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer.
    Johnson RL; Block I; Gold MA; Markwell S; Zupancic M
    Psychooncology; 2010 Sep; 19(9):955-8. PubMed ID: 19918954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of methylphenidate in patients with cancer.
    Sood A; Barton DL; Loprinzi CL
    Am J Hosp Palliat Care; 2006; 23(1):35-40. PubMed ID: 16450661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
    Lower EE; Harman S; Baughman RP
    Chest; 2008 May; 133(5):1189-95. PubMed ID: 18263672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of fatigue: modafinil, methylphenidate, and goals of care.
    Reineke-Bracke H; Radbruch L; Elsner F
    J Palliat Med; 2006 Oct; 9(5):1210-4. PubMed ID: 17040162
    [No Abstract]   [Full Text] [Related]  

  • 31. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.
    Butler JM; Case LD; Atkins J; Frizzell B; Sanders G; Griffin P; Lesser G; McMullen K; McQuellon R; Naughton M; Rapp S; Stieber V; Shaw EG
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1496-501. PubMed ID: 17869448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methylphenidate and cannabinoids may have a place in palliative care. Literature review and clinical experience provides evidence].
    Björkhem-Bergman L; Wallin C
    Lakartidningen; 2013 Aug 7-20; 110(32-33):1409-11. PubMed ID: 23980382
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial.
    Lower EE; Fleishman S; Cooper A; Zeldis J; Faleck H; Yu Z; Manning D
    J Pain Symptom Manage; 2009 Nov; 38(5):650-62. PubMed ID: 19896571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients.
    Escalante CP; Meyers C; Reuben JM; Wang X; Qiao W; Manzullo E; Alvarez RH; Morrow PK; Gonzalez-Angulo AM; Wang XS; Mendoza T; Liu W; Holmes H; Hwang J; Pisters K; Overman M; Cleeland C
    Cancer J; 2014; 20(1):8-14. PubMed ID: 24445757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychotropic drugs for the management of cancer-related fatigue: a systematic review and meta-analysis.
    Qu D; Zhang Z; Yu X; Zhao J; Qiu F; Huang J
    Eur J Cancer Care (Engl); 2016 Nov; 25(6):970-979. PubMed ID: 26490083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naturalistic long-term use of methylphenidate in bipolar disorder.
    Lydon E; El-Mallakh RS
    J Clin Psychopharmacol; 2006 Oct; 26(5):516-8. PubMed ID: 16974196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of clinical trials of pharmacologic interventions for cancer-related fatigue: focus on psychostimulants and steroids.
    Yennurajalingam S; Bruera E
    Cancer J; 2014; 20(5):319-24. PubMed ID: 25299141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of Responses to Corticosteroids for Cancer-Related Fatigue in Advanced Cancer Patients: A Multicenter, Prospective, Observational Study.
    Matsuo N; Morita T; Matsuda Y; Okamoto K; Matsumoto Y; Kaneishi K; Odagiri T; Sakurai H; Katayama H; Mori I; Yamada H; Watanabe H; Yokoyama T; Yamaguchi T; Nishi T; Shirado A; Hiramoto S; Watanabe T; Kohara H; Shimoyama S; Aruga E; Baba M; Sumita K; Iwase S
    J Pain Symptom Manage; 2016 Jul; 52(1):64-72. PubMed ID: 27233138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cochrane review summary for cancer nursing: drug therapy for the management of cancer-related fatigue.
    Chan R
    Cancer Nurs; 2011; 34(3):250-1. PubMed ID: 21512346
    [No Abstract]   [Full Text] [Related]  

  • 40. Question 1: Is methylphenidate a useful treatment for cancer-related fatigue in children?
    Sharp V; Finlay F; Kevitiyagala D
    Arch Dis Child; 2013 Jan; 98(1):80-2. PubMed ID: 23255040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.